275 related articles for article (PubMed ID: 12429964)
1. Adenoviral gene therapy for cancer: from vectors to targeted and replication competent agents (review).
Bauerschmitz GJ; Barker SD; Hemminki A
Int J Oncol; 2002 Dec; 21(6):1161-74. PubMed ID: 12429964
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral vectors: systemic delivery and tumor targeting.
Green NK; Seymour LW
Cancer Gene Ther; 2002 Dec; 9(12):1036-42. PubMed ID: 12522442
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral strategies for the gene therapy of cancer.
Relph KL; Harrington KJ; Pandha H
Semin Oncol; 2005 Dec; 32(6):573-82. PubMed ID: 16338423
[TBL] [Abstract][Full Text] [Related]
5. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
6. Insulated hsp70B' promoter: stringent heat-inducible activity in replication-deficient, but not replication-competent adenoviruses.
Rohmer S; Mainka A; Knippertz I; Hesse A; Nettelbeck DM
J Gene Med; 2008 Apr; 10(4):340-54. PubMed ID: 18265421
[TBL] [Abstract][Full Text] [Related]
7. From gene therapy to virotherapy for ovarian cancer.
Stoff-Khalili MA; Dall P; Curiel DT
Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
[TBL] [Abstract][Full Text] [Related]
8. Replication-selective oncolytic viruses in the treatment of cancer.
Everts B; van der Poel HG
Cancer Gene Ther; 2005 Feb; 12(2):141-61. PubMed ID: 15472714
[TBL] [Abstract][Full Text] [Related]
9. Clinical research results with dl1520 (Onyx-015), a replication-selective adenovirus for the treatment of cancer: what have we learned?
Kirn D
Gene Ther; 2001 Jan; 8(2):89-98. PubMed ID: 11313778
[TBL] [Abstract][Full Text] [Related]
10. [Conditionally replicative adenoviruses: a second wind for cancer gene therapy].
Grill J; Geoerger B; Lamfers M; Dirven C; Van Beusechem V; Gerritsen W; Vassal G
Bull Cancer; 2003 Dec; 90(12):1039-48. PubMed ID: 14715423
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
12. [Oncolytic viruses for genetic therapy of gastrointestinal tumors].
Bitzer M; Lauer UM
Z Gastroenterol; 2003 Jul; 41(7):667-74. PubMed ID: 12858239
[TBL] [Abstract][Full Text] [Related]
13. Gene therapy developments for pancreatic cancer.
Bhattacharyya M; Lemoine NR
Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):285-98. PubMed ID: 16549328
[TBL] [Abstract][Full Text] [Related]
14. Replication-selective oncolytic adenoviruses: virotherapy aimed at genetic targets in cancer.
Kirn D
Oncogene; 2000 Dec; 19(56):6660-9. PubMed ID: 11426652
[TBL] [Abstract][Full Text] [Related]
15. Viral gene therapy strategies: from basic science to clinical application.
Young LS; Searle PF; Onion D; Mautner V
J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
[TBL] [Abstract][Full Text] [Related]
16. Progress towards gene therapy for cancer.
Marchisone C; Pfeffer U; Del Grosso F; Noonan DM; Santi L; Albini A
J Exp Clin Cancer Res; 2000 Sep; 19(3):261-70. PubMed ID: 11144517
[TBL] [Abstract][Full Text] [Related]
17. The secretory leukoprotease inhibitor (SLPI) promoter for ovarian cancer gene therapy.
Barker SD; Coolidge CJ; Kanerva A; Hakkarainen T; Yamamoto M; Liu B; Rivera AA; Bhoola SM; Barnes MN; Alvarez RD; Curiel DT; Hemminki A
J Gene Med; 2003 Apr; 5(4):300-10. PubMed ID: 12692864
[TBL] [Abstract][Full Text] [Related]
18. Replicative adenoviruses for cancer therapy.
Alemany R; Balagué C; Curiel DT
Nat Biotechnol; 2000 Jul; 18(7):723-7. PubMed ID: 10888838
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targeting of adenoviral vector through the CXCR4 tumor-specific promoter.
Zhu ZB; Makhija SK; Lu B; Wang M; Kaliberova L; Liu B; Rivera AA; Nettelbeck DM; Mahasreshti PJ; Leath CA; Yamamoto M; Alvarez RD; Curiel DT
Gene Ther; 2004 Apr; 11(7):645-8. PubMed ID: 15029227
[TBL] [Abstract][Full Text] [Related]
20. Oncolytic adenoviral therapy for glioblastoma multiforme.
Sonabend AM; Ulasov IV; Han Y; Lesniak MS
Neurosurg Focus; 2006 Apr; 20(4):E19. PubMed ID: 16709024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]